| Trial ID: | L1139 |
| Source ID: | NCT02199444
|
| Associated Drug: |
Sevelamer
|
| Title: |
Effect of Sevelamer on P-cresol Levels in CKD
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease Stage 3-5
|
| Interventions: |
DRUG: Sevelamer|DRUG: Placebo
|
| Outcome Measures: |
Primary: Effect on p-creol levels, The p-cresol levels will be evaluated in plasma samples withdrawn after 1, 2 and 3 months of therapy., 3 months |
|
| Sponsor/Collaborators: |
Sponsor: Federico II University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
200
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
|
| Start Date: |
2014-06
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2015-02-18
|
| Locations: |
federico II university, department of nephrology, Naples, 80131, Italy
|
| URL: |
https://clinicaltrials.gov/show/NCT02199444
|
